Valuation: Stryker Corporation

Market Cap 106B 1,817B 91.88B 86.72B 78.79B 148B 10,118B 148B 1,037B 401B 5,146B 396B 388B 16,553B P/E 2026 *
21.4x
P/E 2027 * 18.6x
Enterprise Value 115B 1,974B 99.82B 94.22B 85.61B 160B 10,993B 161B 1,127B 435B 5,591B 431B 421B 17,984B EV / Sales 2026 *
4.21x
EV / Sales 2027 * 3.76x
Free-Float
94.9%
Yield 2026 *
1.31%
Yield 2027 * 1.39%
1 day+1.22%
1 week+1.22%
Current month-13.29%
1 month-16.93%
3 months-9.04%
6 months-22.69%
Current year-24.56%
1 week 4,828
Extreme 4828
4,828
1 month 4,770
Extreme 4770
5,568.24
Current year 4,770
Extreme 4770
6,769.22
1 year 4,770
Extreme 4770
6,982
3 years 4,663.01
Extreme 4663.01
8,216
5 years 3,953.6
Extreme 3953.6
8,216
10 years 2,469
Extreme 2469
8,216
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
President 49 01/01/2026
Director of Finance/CFO 50 01/04/2025
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%+1.22% - - 106B
-1.79%-0.16%-27.19%-6.17% 106B
-0.77%+1.88%-24.84%-2.00% 11.56B
+1.48%-2.06%+90.83%+116.88% 9.66B
+0.75%+2.06%-52.06%-71.12% 4.02B
+0.39%+0.36%-28.86%+21.76% 2.34B
+5.55%+5.18%-7.94%-63.46% 2.22B
+4.97%+4.82% - - 1.93B
+0.72%+1.95%-20.50%-29.27% 1.53B
Average +1.39%+1.47%-10.08%-4.77% 17.35B
Weighted average by Cap. -0.11%+0.08%-19.03%+0.24%

Financials

2026 *2027 *
Net sales 27.25B 469B 23.73B 22.4B 20.35B 38.12B 2,613B 38.29B 268B 103B 1,329B 102B 100B 4,275B 29.63B 510B 25.8B 24.35B 22.12B 41.44B 2,841B 41.63B 291B 112B 1,445B 111B 109B 4,647B
Net income 4.94B 85.1B 4.3B 4.06B 3.69B 6.91B 474B 6.94B 48.57B 18.76B 241B 18.56B 18.15B 775B 5.75B 98.94B 5B 4.72B 4.29B 8.04B 551B 8.07B 56.47B 21.81B 280B 21.58B 21.1B 901B
Net Debt 9.13B 157B 7.94B 7.5B 6.81B 12.76B 875B 12.82B 89.69B 34.64B 445B 34.28B 33.52B 1,431B 5.89B 101B 5.13B 4.84B 4.4B 8.24B 565B 8.28B 57.92B 22.37B 287B 22.13B 21.64B 924B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
275.12USD
Average target price
374.28USD
Spread / Average Target
+36.04%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!